Trial Profile
Effect of ivabradine on periprocedural myocardial injury and infarction in percutaneous coronary intervention undergoing patients with stable angina
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Mar 2015
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Angina pectoris; Myocardial infarction
- Focus Pharmacodynamics
- 23 Mar 2015 New trial record